-
1
-
-
34249064632
-
Epstein-Barr virus
-
Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), 5th ed Lippincott Williams & Wilkins, Philadelphia, PA
-
Rickinson AB, KieffE. 2007. Epstein-Barr virus, p 2655-2700. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
-
(2007)
Fields virology
, pp. 2655-2700
-
-
Rickinson, A.B.1
Kieff, E.2
-
2
-
-
56949100257
-
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products
-
Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ. 2008. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. Semin Cancer Biol 18:397-408. http://dx.doi.org/10.1016/j.semcancer.2008.10.008.
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 397-408
-
-
Ressing, M.E.1
Horst, D.2
Griffin, B.D.3
Tellam, J.4
Zuo, J.5
Khanna, R.6
Rowe, M.7
Wiertz, E.J.8
-
3
-
-
76549087625
-
Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+T cell immunity
-
Rowe M, Zuo J. 2010. Immune responses to Epstein-Barr virus: molecular interactions in the virus evasion of CD8+T cell immunity. Microbes Infect 12:173-181. http://dx.doi.org/10.1016/j.micinf.2009.12.001.
-
(2010)
Microbes Infect
, vol.12
, pp. 173-181
-
-
Rowe, M.1
Zuo, J.2
-
4
-
-
34547755806
-
A CD8+T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates
-
Hislop AD, Ressing ME, van Leeuwen D, Pudney VA, Horst D, Koppers-Lalic D, Croft NP, Neefjes JJ, Rickinson AB, Wiertz EJ. 2007. A CD8+T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates. J Exp Med 204:1863-1873. http://dx.doi.org/10.1084/jem.20070256.
-
(2007)
J Exp Med
, vol.204
, pp. 1863-1873
-
-
Hislop, A.D.1
Ressing, M.E.2
van Leeuwen, D.3
Pudney, V.A.4
Horst, D.5
Koppers-Lalic, D.6
Croft, N.P.7
Neefjes, J.J.8
Rickinson, A.B.9
Wiertz, E.J.10
-
5
-
-
33847615627
-
Host shutoffduring productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion
-
Rowe M, Glaunsinger B, van Leeuwen D, Zuo J, Sweetman D, Ganem D, Middeldorp J, Wiertz EJ, Ressing ME. 2007. Host shutoffduring productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A 104:3366-3371. http://dx.doi.org/10.1073/pnas.0611128104.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 3366-3371
-
-
Rowe, M.1
Glaunsinger, B.2
van Leeuwen, D.3
Zuo, J.4
Sweetman, D.5
Ganem, D.6
Middeldorp, J.7
Wiertz, E.J.8
Ressing, M.E.9
-
6
-
-
0030881322
-
Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10
-
Zeidler R, Eissner G, Meissner P, Uebel S, Tampe R, Lazis S, Hammer-schmidt W. 1997. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90:2390-2397.
-
(1997)
Blood
, vol.90
, pp. 2390-2397
-
-
Zeidler, R.1
Eissner, G.2
Meissner, P.3
Uebel, S.4
Tampe, R.5
Lazis, S.6
Hammer-schmidt, W.7
-
7
-
-
59249101973
-
The Epstein-Barr virus G-proteincoupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation
-
Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, Wiertz EJ, Rowe M. 2009. The Epstein-Barr virus G-proteincoupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5:e1000255. http://dx.doi.org/10.1371/journal.ppat.1000255.
-
(2009)
PLoS Pathog
, vol.5
-
-
Zuo, J.1
Currin, A.2
Griffin, B.D.3
Shannon-Lowe, C.4
Thomas, W.A.5
Ressing, M.E.6
Wiertz, E.J.7
Rowe, M.8
-
9
-
-
19944426837
-
Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion
-
Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, OttenhoffTH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, Rowe M, Wiertz EJ. 2005. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J Virol 79:841-852. http://dx.doi.org/10.1128/JVI.79.2.841-852.2005.
-
(2005)
J Virol
, vol.79
, pp. 841-852
-
-
Ressing, M.E.1
van Leeuwen, D.2
Verreck, F.A.3
Keating, S.4
Gomez, R.5
Franken, K.L.6
Ottenhoff, T.H.7
Spriggs, M.8
Schumacher, T.N.9
Hutt-Fletcher, L.M.10
Rowe, M.11
Wiertz, E.J.12
-
10
-
-
0141816757
-
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition
-
Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, OttenhoffTH, Neefjes J, Schumacher TN, Hutt-Fletcher LM, Wiertz EJ. 2003. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A 100:11583-11588. http://dx.doi.org/10.1073/pnas.2034960100.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 11583-11588
-
-
Ressing, M.E.1
van Leeuwen, D.2
Verreck, F.A.3
Gomez, R.4
Heemskerk, B.5
Toebes, M.6
Mullen, M.M.7
Jardetzky, T.S.8
Longnecker, R.9
Schilham, M.W.10
Ottenhoff, T.H.11
Neefjes, J.12
Schumacher, T.N.13
Hutt-Fletcher, L.M.14
Wiertz, E.J.15
-
12
-
-
78951479559
-
The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways
-
Zuo J, Quinn LL, Tamblyn J, Thomas WA, Feederle R, Delecluse HJ, Hislop AD, Rowe M. 2011. The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways. J Virol 85:1604-1614. http://dx.doi.org/10.1128/JVI.01608-10.
-
(2011)
J Virol
, vol.85
, pp. 1604-1614
-
-
Zuo, J.1
Quinn, L.L.2
Tamblyn, J.3
Thomas, W.A.4
Feederle, R.5
Delecluse, H.J.6
Hislop, A.D.7
Rowe, M.8
-
13
-
-
84873564255
-
EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail
-
Griffin BD, Gram AM, Mulder A, Van Leeuwen D, Claas FH, Wang F, Ressing ME, Wiertz E. 2013. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol 190:1672-1684. http://dx.doi.org/10.4049/jimmunol.1102462.
-
(2013)
J Immunol
, vol.190
, pp. 1672-1684
-
-
Griffin, B.D.1
Gram, A.M.2
Mulder, A.3
Van Leeuwen, D.4
Claas, F.H.5
Wang, F.6
Ressing, M.E.7
Wiertz, E.8
-
14
-
-
67650863635
-
Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle
-
Croft NP, Shannon-Lowe C, Bell AI, Horst D, Kremmer E, Ressing ME, Wiertz EJ, Middeldorp JM, Rowe M, Rickinson AB, Hislop AD. 2009. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle. PLoS Pathog 5:e1000490. http://dx.doi.org/10.1371/journal.ppat.1000490.
-
(2009)
PLoS Pathog
, vol.5
-
-
Croft, N.P.1
Shannon-Lowe, C.2
Bell, A.I.3
Horst, D.4
Kremmer, E.5
Ressing, M.E.6
Wiertz, E.J.7
Middeldorp, J.M.8
Rowe, M.9
Rickinson, A.B.10
Hislop, A.D.11
-
15
-
-
61449138716
-
Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation
-
Horst D, van Leeuwen D, Croft NP, Garstka MA, Hislop AD, Kremmer E, Rickinson AB, Wiertz EJ, Ressing ME. 2009. Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation. J Immunol 182:2313-2324. http://dx.doi.org/10.4049/jimmunol.0803218.
-
(2009)
J Immunol
, vol.182
, pp. 2313-2324
-
-
Horst, D.1
van Leeuwen, D.2
Croft, N.P.3
Garstka, M.A.4
Hislop, A.D.5
Kremmer, E.6
Rickinson, A.B.7
Wiertz, E.J.8
Ressing, M.E.9
-
16
-
-
84927668370
-
Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+T cell recognition across all three phases of the lytic cycle
-
Quinn LL, Zuo J, Abbott RJ, Shannon-Lowe C, Tierney RJ, Hislop AD, Rowe M. 2014. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+T cell recognition across all three phases of the lytic cycle. PLoS Pathog 10:e1004322. http://dx.doi.org/10.1371/journal.ppat.1004322.
-
(2014)
PLoS Pathog
, vol.10
-
-
Quinn, L.L.1
Zuo, J.2
Abbott, R.J.3
Shannon-Lowe, C.4
Tierney, R.J.5
Hislop, A.D.6
Rowe, M.7
-
17
-
-
13644262179
-
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
-
Pudney VA, Leese AM, Rickinson AB, Hislop AD. 2005. CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells. J Exp Med 201:349-360. http://dx.doi.org/10.1084/jem.20041542.
-
(2005)
J Exp Med
, vol.201
, pp. 349-360
-
-
Pudney, V.A.1
Leese, A.M.2
Rickinson, A.B.3
Hislop, A.D.4
-
18
-
-
0031821276
-
Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells
-
Borza CM, Hutt-Fletcher LM. 1998. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of epithelial cells. J Virol 72:7577-7582.
-
(1998)
J Virol
, vol.72
, pp. 7577-7582
-
-
Borza, C.M.1
Hutt-Fletcher, L.M.2
-
19
-
-
0029037298
-
A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame
-
Kurilla MG, Heineman T, Davenport LC, KieffE, Hutt-Fletcher LM. 1995. A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame. Virology 209:108-121. http://dx.doi.org/10.1006/viro.1995.1235.
-
(1995)
Virology
, vol.209
, pp. 108-121
-
-
Kurilla, M.G.1
Heineman, T.2
Davenport, L.C.3
Kieff, E.4
Hutt-Fletcher, L.M.5
-
20
-
-
0029014537
-
The Epstein-Barr virus open reading frame BDLF3 codes for a 100-150 kDa glycoprotein
-
Nolan LA, Morgan AJ. 1995. The Epstein-Barr virus open reading frame BDLF3 codes for a 100-150 kDa glycoprotein. J Gen Virol 76:1381-1392. http://dx.doi.org/10.1099/0022-1317-76-6-1381.
-
(1995)
J Gen Virol
, vol.76
, pp. 1381-1392
-
-
Nolan, L.A.1
Morgan, A.J.2
-
21
-
-
76649105133
-
Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display
-
Leung CS, Haigh TA, Mackay LK, Rickinson AB, Taylor GS. 2010. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc Natl Acad Sci U S A 107:2165-2170. http://dx.doi.org/10.1073/pnas.0909448107.
-
(2010)
Proc Natl Acad Sci U S A
, vol.107
, pp. 2165-2170
-
-
Leung, C.S.1
Haigh, T.A.2
Mackay, L.K.3
Rickinson, A.B.4
Taylor, G.S.5
-
22
-
-
0019840456
-
Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin
-
Johnson JP, Demmer-Dieckmann M, Meo T, Hadam MR, Riethmuller G. 1981. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Eur J Immunol 11:825-831.
-
(1981)
Eur J Immunol
, vol.11
, pp. 825-831
-
-
Johnson, J.P.1
Demmer-Dieckmann, M.2
Meo, T.3
Hadam, M.R.4
Riethmuller, G.5
-
23
-
-
0017329178
-
Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75)
-
Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM, Bentwich Z, Ramot B, Klein E, Klein G. 1977. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19:27-33. http://dx.doi.org/10.1002/ijc.2910190105.
-
(1977)
Int J Cancer
, vol.19
, pp. 27-33
-
-
Ben-Bassat, H.1
Goldblum, N.2
Mitrani, S.3
Goldblum, T.4
Yoffey, J.M.5
Cohen, M.M.6
Bentwich, Z.7
Ramot, B.8
Klein, E.9
Klein, G.10
-
24
-
-
84857753994
-
+ T cells
-
+ T cells. Blood 119:2083-2092. http://dx.doi.org/10.1182/blood-2011-07-366476.
-
(2012)
Blood
, vol.119
, pp. 2083-2092
-
-
Sabbah, S.1
Jagne, Y.J.2
Zuo, J.3
de Silva, T.4
Ahasan, M.M.5
Brander, C.6
Rowland-Jones, S.7
Flanagan, K.L.8
Hislop, A.D.9
-
25
-
-
0019413925
-
Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells
-
Rabin H, Hopkins RF, III, Ruscetti FW, Neubauer RH, Brown RL, Kawakami TG. 1981. Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol 127:1852-1856.
-
(1981)
J Immunol
, vol.127
, pp. 1852-1856
-
-
Rabin, H.1
Hopkins, R.F.2
Ruscetti, F.W.3
Neubauer, R.H.4
Brown, R.L.5
Kawakami, T.G.6
-
26
-
-
0018154865
-
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis
-
Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9-20. http://dx.doi.org/10.1016/0092-8674(78)90296-9.
-
(1978)
Cell
, vol.14
, pp. 9-20
-
-
Barnstable, C.J.1
Bodmer, W.F.2
Brown, G.3
Galfre, G.4
Milstein, C.5
Williams, A.F.6
Ziegler, A.7
-
27
-
-
0026058670
-
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia
-
Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB, Farrell PJ. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65:2868-2874.
-
(1991)
J Virol
, vol.65
, pp. 2868-2874
-
-
Young, L.S.1
Lau, R.2
Rowe, M.3
Niedobitek, G.4
Packham, G.5
Shanahan, F.6
Rowe, D.T.7
Greenspan, D.8
Greenspan, J.S.9
Rickinson, A.B.10
Farrell, P.J.11
-
28
-
-
61449105702
-
Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation
-
Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N. 2009. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. J Immunol 182:1799-1809. http://dx.doi.org/10.4049/jimmunol.0802686.
-
(2009)
J Immunol
, vol.182
, pp. 1799-1809
-
-
Li, D.1
Qian, L.2
Chen, C.3
Shi, M.4
Yu, M.5
Hu, M.6
Song, L.7
Shen, B.8
Guo, N.9
-
29
-
-
84877357964
-
Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and-independent mechanisms: implications for oncogenesis
-
Zuo J, Hislop AD, Leung CS, Sabbah S, Rowe M. 2013. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and-independent mechanisms: implications for oncogenesis. J Virol 87:5340-5350. http://dx.doi.org/10.1128/JVI.00250-13.
-
(2013)
J Virol
, vol.87
, pp. 5340-5350
-
-
Zuo, J.1
Hislop, A.D.2
Leung, C.S.3
Sabbah, S.4
Rowe, M.5
-
30
-
-
0032863467
-
+ T cells
-
+ T cells. NatMed5:1039-1043. http://dx.doi.org/10.1038/12478.
-
(1999)
NatMed
, vol.5
, pp. 1039-1043
-
-
Tomazin, R.1
Boname, J.2
Hegde, N.R.3
Lewinsohn, D.M.4
Altschuler, Y.5
Jones, T.R.6
Cresswell, P.7
Nelson, J.A.8
Riddell, S.R.9
Johnson, D.C.10
-
31
-
-
9244222166
-
Proteins of purified Epstein-Barr virus
-
Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, KieffE. 2004. Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A 101:16286-16291. http://dx.doi.org/10.1073/pnas.0407320101.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 16286-16291
-
-
Johannsen, E.1
Luftig, M.2
Chase, M.R.3
Weicksel, S.4
Cahir-McFarland, E.5
Illanes, D.6
Sarracino, D.7
Kieff, E.8
-
32
-
-
0034608951
-
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display ofMHCclass I chains by enhancing their endocytosis
-
Coscoy L, Ganem D. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display ofMHCclass I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97:8051-8056. http://dx.doi.org/10.1073/pnas.140129797.
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 8051-8056
-
-
Coscoy, L.1
Ganem, D.2
-
33
-
-
0034068631
-
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins
-
Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74:5300-5309. http://dx.doi.org/10.1128/JVI.74.11.5300-5309.2000.
-
(2000)
J Virol
, vol.74
, pp. 5300-5309
-
-
Ishido, S.1
Wang, C.2
Lee, B.S.3
Cohen, G.B.4
Jung, J.U.5
-
35
-
-
0035022210
-
Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8
-
Haque M, Ueda K, Nakano K, Hirata Y, Parravicini C, Corbellino M, Yamanishi K. 2001. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J Gen Virol 82:1175-1180. http://dx.doi.org/10.1099/0022-1317-82-5-1175.
-
(2001)
J Gen Virol
, vol.82
, pp. 1175-1180
-
-
Haque, M.1
Ueda, K.2
Nakano, K.3
Hirata, Y.4
Parravicini, C.5
Corbellino, M.6
Yamanishi, K.7
-
36
-
-
26244468727
-
Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases
-
Lehner PJ, Hoer S, Dodd R, Duncan LM. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207:112-125. http://dx.doi.org/10.1111/j.0105-2896.2005.00314.x.
-
(2005)
Immunol Rev
, vol.207
, pp. 112-125
-
-
Lehner, P.J.1
Hoer, S.2
Dodd, R.3
Duncan, L.M.4
-
37
-
-
84904883591
-
Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication
-
Brulois K, Toth Z, Wong LY, Feng P, Gao SJ, Ensser A, Jung JU. 2014. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication. J Virol 88:9335-9349. http://dx.doi.org/10.1128/JVI.00873-14.
-
(2014)
J Virol
, vol.88
, pp. 9335-9349
-
-
Brulois, K.1
Toth, Z.2
Wong, L.Y.3
Feng, P.4
Gao, S.J.5
Ensser, A.6
Jung, J.U.7
-
38
-
-
33750470785
-
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators
-
Bartee E, McCormack A, Fruh K. 2006. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2:e107. http://dx.doi.org/10.1371/journal.ppat.0020107.
-
(2006)
PLoS Pathog
, vol.2
-
-
Bartee, E.1
McCormack, A.2
Fruh, K.3
-
39
-
-
84888267145
-
Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases
-
Timms RT, Duncan LM, Tchasovnikarova IA, Antrobus R, Smith DL, Dougan G, Weekes MP, Lehner PJ. 2013. Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases. PLoS Pathog 9:e1003772. http://dx.doi.org/10.1371/journal.ppat.1003772.
-
(2013)
PLoS Pathog
, vol.9
-
-
Timms, R.T.1
Duncan, L.M.2
Tchasovnikarova, I.A.3
Antrobus, R.4
Smith, D.L.5
Dougan, G.6
Weekes, M.P.7
Lehner, P.J.8
-
40
-
-
18244402636
-
Regulation of CD1d expression and function by a herpesvirus infection
-
Sanchez DJ, Gumperz JE, Ganem D. 2005. Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115:1369-1378. http://dx.doi.org/10.1172/JCI200524041.
-
(2005)
J Clin Invest
, vol.115
, pp. 1369-1378
-
-
Sanchez, D.J.1
Gumperz, J.E.2
Ganem, D.3
-
41
-
-
40349108461
-
Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity
-
Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ. 2008. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A 105:1656-1661. http://dx.doi.org/10.1073/pnas.0707883105.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 1656-1661
-
-
Thomas, M.1
Boname, J.M.2
Field, S.3
Nejentsev, S.4
Salio, M.5
Cerundolo, V.6
Wills, M.7
Lehner, P.J.8
-
42
-
-
33847238748
-
Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5
-
Li Q, Means R, Lang S, Jung JU. 2007. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81:2117-2127. http://dx.doi.org/10.1128/JVI.01961-06.
-
(2007)
J Virol
, vol.81
, pp. 2117-2127
-
-
Li, Q.1
Means, R.2
Lang, S.3
Jung, J.U.4
-
43
-
-
0346373729
-
Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins
-
Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Fruh K. 2004. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120. http://dx.doi.org/10.1128/JVI.78.3.1109-1120.2004.
-
(2004)
J Virol
, vol.78
, pp. 1109-1120
-
-
Bartee, E.1
Mansouri, M.2
Hovey Nerenberg, B.T.3
Gouveia, K.4
Fruh, K.5
-
44
-
-
33750369258
-
A novel family of membrane-bound E3 ubiquitin ligases
-
Ohmura-Hoshino M, Goto E, Matsuki Y, Aoki M, Mito M, Uematsu M, Hotta H, Ishido S. 2006. A novel family of membrane-bound E3 ubiquitin ligases. J Biochem 140:147-154. http://dx.doi.org/10.1093/jb/mvj160.
-
(2006)
J Biochem
, vol.140
, pp. 147-154
-
-
Ohmura-Hoshino, M.1
Goto, E.2
Matsuki, Y.3
Aoki, M.4
Mito, M.5
Uematsu, M.6
Hotta, H.7
Ishido, S.8
-
45
-
-
33745312078
-
Inhibition of MHC class II expression and immune responses by c-MIR
-
Ohmura-Hoshino M, Matsuki Y, Aoki M, Goto E, Mito M, Uematsu M, Kakiuchi T, Hotta H, Ishido S. 2006. Inhibition of MHC class II expression and immune responses by c-MIR. J Immunol 177:341-354. http://dx.doi.org/10.4049/jimmunol.177.1.341.
-
(2006)
J Immunol
, vol.177
, pp. 341-354
-
-
Ohmura-Hoshino, M.1
Matsuki, Y.2
Aoki, M.3
Goto, E.4
Mito, M.5
Uematsu, M.6
Kakiuchi, T.7
Hotta, H.8
Ishido, S.9
-
46
-
-
33845618137
-
MARCH-IX mediates ubiquitination and downregulation of ICAM-1
-
Hoer S, Smith L, Lehner PJ. 2007. MARCH-IX mediates ubiquitination and downregulation of ICAM-1. FEBS Lett 581:45-51. http://dx.doi.org/10.1016/j.febslet.2006.11.075.
-
(2007)
FEBS Lett
, vol.581
, pp. 45-51
-
-
Hoer, S.1
Smith, L.2
Lehner, P.J.3
-
47
-
-
67349172917
-
The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases
-
Nathan JA, Lehner PJ. 2009. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 315:1593-1600. http://dx.doi.org/10.1016/j.yexcr.2008.10.026.
-
(2009)
Exp Cell Res
, vol.315
, pp. 1593-1600
-
-
Nathan, J.A.1
Lehner, P.J.2
-
48
-
-
22544482352
-
Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate
-
Fogg MH, Carville A, Cameron J, Quink C, Wang F. 2005. Reduced prevalence of Epstein-Barr virus-related lymphocryptovirus infection in sera from a new world primate. J Virol 79:10069-10072. http://dx.doi.org/10.1128/JVI.79.15.10069-10072.2005.
-
(2005)
J Virol
, vol.79
, pp. 10069-10072
-
-
Fogg, M.H.1
Carville, A.2
Cameron, J.3
Quink, C.4
Wang, F.5
-
49
-
-
84880299051
-
Nonhuman primate models for Epstein-Barr virus infection
-
Wang F. 2013. Nonhuman primate models for Epstein-Barr virus infection. Curr Opin Virol 3:233-237. http://dx.doi.org/10.1016/j.coviro.2013.03.003.
-
(2013)
Curr Opin Virol
, vol.3
, pp. 233-237
-
-
Wang, F.1
|